Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study

被引：0

作者：

Rachelle Buchbinder

Sharon Van Doornum

Margaret Staples

Marissa Lassere

Lyn March

机构：

[1] School of Public Health and Preventive Medicine,Department of Epidemiology and Preventive Medicine

[2] Monash University,Monash Department of Clinical Epidemiology

[3] Cabrini Institute,Department of Medicine (Royal Melbourne Hospital)

[4] The University of Melbourne,St George Hospital

[5] University of New South Wales,Florance and Cope Professorial Department of Rheumatology

[6] Royal North Shore Hospital,undefined

[7] Institute of Bone and Joint Research,undefined

[8] University of Sydney ,undefined

来源：

BMC Musculoskeletal Disorders | / 16卷

关键词：

Rheumatoid arthritis; Malignancy; Tumour necrosis factor; Biologic therapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Microarray analysis for molecular characterization of disease activity and measuring outcomes of anti-tumour necrosis factor therapy in rheumatoid arthritis [J].

Stuhlmueller, B. ;

Haeupl, T. ;

Tandon, N. ;

Hernandez, M. ;

Hultschig, C. ;

Kuban, R. J. ;

Salfeld, J. ;

Burmester, G. R. .

ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) :S57-S57

[22] The impact of anti-tumour necrosis factor therapy for rheumatoid arthritis on the use of other drugs and hospital resources in a pragmatic setting [J].

Sandhu, R. S. ;

Treharne, G. J. ;

Douglas, K. M. J. ;

Cassim, K. ;

Saratzis, A. ;

Piper, H. ;

Erb, N. ;

Jenkins, D. ;

Tavakoli, M. ;

Deighton, C. ;

Kitas, G. D. .

MUSCULOSKELETAL CARE, 2006, 4 (04) :204-222

[23] Risk of malignancy including non-melanoma skin cancers with anti-tumour necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies [J].

Le Blay, P. ;

Mouterde, G. ;

Barnetche, T. ;

Morel, J. ;

Combe, B. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (05) :756-764

[24] Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era [J].

Cacciapaglia, F. ;

Zuccaro, C. ;

Iannone, F. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (06) :917-923

[25] Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis [J].

Antonios Stavropoulos-Kalinoglou ;

Giorgos S Metsios ;

Vasileios F Panoulas ;

Peter Nightingale ;

Yiannis Koutedakis ;

George D Kitas .

Arthritis Research & Therapy, 14

[26] The prevalence of patients with rheumatoid arthritis in the West Midlands fulfilling the BSR criteria for anti-tumour necrosis factor therapy: an out-patient study [J].

Yee, CS ;

Filer, A ;

Pace, A ;

Douglas, K ;

Situnayake, D ;

Rowe, IF .

RHEUMATOLOGY, 2003, 42 (07) :856-859

[27] Tuberculosis risk and anti-tumour necrosis factor agents in rheumatoid arthritis: a critical appraisal of national registry data [J].

Scrivo, Rossana ;

Armignacco, Orlando .

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2014, 17 (07) :714-722

[28] Adherence to Subcutaneous Anti-Tumour Necrosis Factor Treatment in a Cohort of Patients with Rheumatoid Arthritis Before and After the Implementation of a Comprehensive Care Model [J].

Santos-Moreno, Pedro ;

Sanchez-Vanegas, Guillermo ;

Monterrosa-Blanco, Angelica ;

Rodriguez-Vargas, Gabriel-Santiago ;

Rivero, Manuel ;

Rodriguez, Pedro ;

Calixto, Omar-Javier ;

Rojas-Villarraga, Adriana ;

Castro, Carlos Alberto .

BIOLOGICS-TARGETS & THERAPY, 2022, 16 :199-209

[29] Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients [J].

Hamann, Philip D. H. ;

Pauling, John D. ;

McHugh, Neil ;

Shaddick, Gavin ;

Hyrich, Kimme ;

Maiden, Nicola ;

Price, Tom ;

Hopkinson, Neil ;

O'Reilly, Sheila ;

Hordon, Lesley ;

Griffiths, Ian ;

Porter, Duncan ;

Capell, Hilary ;

Hassell, Andy ;

Benitha, Romela ;

Choy, Ernest ;

Walsh, David ;

Emery, Paul ;

Knight, Susan ;

Bruce, Ian ;

Taggart, Allister ;

Scott, David ;

Harrison, Bev ;

Thompson, Paul ;

McCrae, Fiona ;

Goodfellow, Rhian ;

Bukhari, Marwan ;

Klimiuk, Peter ;

Kitas, George ;

Jubb, Ronald ;

Abernethy, Rikki ;

Clarke, Shane ;

Green, Sandra ;

Sanders, Paul ;

Coulson, Amanda .

RHEUMATOLOGY, 2019, 58 (12) :2162-2169

[30] Anti-Tumour Necrosis Factor-α Therapy for Rheumatoid and Other Inflammatory ArthropathiesUpdate on Safety in Older Patients [J].

Paul Ornetti ;

Hélène Chevillotte ;

Amal Zerrak ;

Jean Francis Maillefert .

Drugs & Aging, 2006, 23 :855-860

← 1 2 3 4 5 →